| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-06 |